{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T13:28:43Z","timestamp":1655731723143},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.amjcard.2013.08.033","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T17:23:56Z","timestamp":1380734636000},"page":"12-16","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of Statin Alone Versus Bezafibrate and Statin Combination in Patients With Diabetes Mellitus and Acute Coronary Syndrome"],"prefix":"10.1016","volume":"113","author":[{"given":"Robert","family":"Klempfner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique Z.","family":"Fisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomi","family":"Matetzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uri","family":"Amit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Shemesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Tenenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2013.08.033_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/eurheartj\/ehm124","volume":"28","author":"Ryd\u00e9n","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2013.08.033_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1475-2840-11-78","article-title":"The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively","volume":"11","author":"Mazurek","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2013.08.033_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3132\/dvdr.2005.022","article-title":"Management of patients with type 2 DM after acute coronary syndromes","volume":"2","author":"Bartnik","year":"2005","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.amjcard.2013.08.033_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1479164111427752","article-title":"Association of DM with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era","volume":"9","author":"Kahn","year":"2012","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.amjcard.2013.08.033_bib5","first-page":"81","article-title":"Diabetes mellitus and acute coronary syndrome","volume":"101","author":"Keller","year":"2010","journal-title":"Minerva Med"},{"issue":"suppl","key":"10.1016\/j.amjcard.2013.08.033_bib6","doi-asserted-by":"crossref","first-page":"13B","DOI":"10.1016\/j.amjcard.2012.08.035","article-title":"Additive impact of diabetes mellitus on patients with metabolic syndrome and acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"110","author":"Sanon","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2013.08.033_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","article-title":"Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes mellitus, and cardiovascular disease? The common soil hypothesis revisited","volume":"24","author":"Ceriello","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2013.08.033_bib8","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","article-title":"Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: part I","volume":"108","author":"Creager","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.08.033_bib9","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/01.CIR.0000012467.61045.87","article-title":"Adaptation and maladaptation of the heart in diabetes mellitus. Part II. Potential mechanisms","volume":"105","author":"Young","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.08.033_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.102.1.21","article-title":"Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study","volume":"102","author":"The BIP Study Group","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.08.033_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2840-11-125","article-title":"Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction","volume":"11","author":"Tenenbaum","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2013.08.033_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/bmj.325.7373.1139","article-title":"Bezafibrate in men with lower extremity arterial disease: randomised controlled trial","volume":"325","author":"Meade","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2013.08.033_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijcard.2004.03.071","article-title":"Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia\u2014a nuclear magnetic resonance study","volume":"101","author":"Ikewaki","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2013.08.033_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9343(01)01123-8","article-title":"Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial","volume":"112","author":"Jonkers","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2013.08.033_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-2840-11-29","article-title":"Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with DM: the J-BENEFIT study","volume":"11","author":"Teramoto","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2013.08.033_bib16","first-page":"229","article-title":"Impact of bezafibrate treatment in patients with hyperfibrinogenemia and ST-elevation acute myocardial infarction: a randomized clinical trial","volume":"78","author":"Madrid-Miller","year":"2010","journal-title":"Cir Cir"},{"key":"10.1016\/j.amjcard.2013.08.033_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1475-2840-11-140","article-title":"Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes mellitus prevention?","volume":"11","author":"Tenenbaum","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2013.08.033_bib18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00228-011-1063-y","article-title":"The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia","volume":"67","author":"Krysiak","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2013.08.033_bib19","doi-asserted-by":"crossref","first-page":"e35298","DOI":"10.1371\/journal.pone.0035298","article-title":"Cardiovascular events in patients received combined fibrate\/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data","volume":"7","author":"Tenenbaum","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2013.08.033_bib20","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/euhj.2000.2317","article-title":"Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study","volume":"21","author":"McGuire","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2013.08.033_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2003.07.024","article-title":"Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes","volume":"147","author":"McGuire","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2013.08.033_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.298.7.765","article-title":"Diabetes and mortality following acute coronary syndromes","volume":"298","author":"Donahoe","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2013.08.033_bib23","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2013.08.033_bib24","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2013.08.033_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.atherosclerosis.2006.11.035","article-title":"Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia","volume":"196","author":"Ayaori","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2013.08.033_bib26","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archinte.165.10.1154","article-title":"Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome","volume":"165","author":"Tenenbaum","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2013.08.033_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jacc.2007.09.048","article-title":"Secondary prevention with bezafibrate therapy for the treatment of dyslipidemia: an extended follow-up of the BIP trial","volume":"51","author":"Goldenberg","year":"2008","journal-title":"Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2013.08.033_bib28","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2013.08.033_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2796.2000.00646.x","article-title":"Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety","volume":"247","author":"Gavish","year":"2000","journal-title":"J\u00a0Intern Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914913019176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914913019176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,28]],"date-time":"2019-07-28T11:49:20Z","timestamp":1564314560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914913019176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0002914913019176"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2013.08.033","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}